medigraphic.com
Colegio de Medicina Interna de México.

2006, Number 5

<< Back Next >>

Med Int Mex 2006; 22 (5)

Disseminated histoplasmosis in a patient with systemic lupus erythematosus

Mustieles C, Ramírez R, Nellen H, Tejeda B

Language: Spanish
References: 11
Page: 462-464
PDF size: 158.01 Kb.


ABSTRACT

Opportunistic infection is common in patients with systemic lupus erythematosus (SLE). In some patients, it is difficult to distinguished between the effect of infection and exacerbation of SLE because both can produce similar symptoms. We present a case of a woman with fever who developed hemolytic anemia, lymphopenia, pleural and pericardial effusion, serum antinuclear antibodies and anti-DNA antibodies. She was diagnosed with SLE and received corticosteroids. After this, she developed disseminated histoplasmosis. Clinicians should be alert to the possibility of opportunistic infection in patients with SLE in cases characterized by fever, atypical clinical patterns, or poor reponse to immunosuppresive therapy.


REFERENCES

  1. Staples PJ, Gerding DN, Decker JL, Gordon RS. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-10.

  2. Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematous. Semin Arthritis Rheum 1996;25:318-36.

  3. Gescuk BD, Davis JC. Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheum 2002;4:515-21.

  4. Bouza E, García-Lechuz J, Muñoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infec Dis Clin North Am 2001;15:1-28.

  5. Kang I, Hwan Park S. Infectious complications in SLE after immunosuppresive therapies. Curr Opinion in Rheumatol 2003; 15:528-34.

  6. Noel V, Lorholary O, Casassus P, Cohen P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematous. Ann Rheum Dis 2001; 60:1141-4.

  7. Sieving RR, Kauffman CA, Watanakunakorn C. Deep fungal infection in systemic lupus erythematosus- three cases reported, literature reviewed. J Rheumatol 1975; 2: 61-72.

  8. Hansen KE, St Clair EW. Disseminated histoplasmosis in Systemic Lupus Erythematosus: Case Report and Review of the Literature. Semin Arthritis Rheum 1998; 28:193-99.

  9. Caplivski D, Salama C, Huprikar S, Bottone E. Disseminated histoplasmosis in five immunosuppressed patients: clinical, diagnostic, and therapeutic perspectives. Rev Med Microbiology 2005;16:1-7.

  10. Lionakis M, Kontoyiannis D. Glucocorticoids and invasive fungal infections. Lancet 2003; 362:1828-38.

  11. Kaukkman CA, Israel KS, Smith JW, White AC, et. al. Histoplasmosis in immunosuppresed patients. Am J Med 1978; 64:923-32.




2020     |     www.medigraphic.com